This Article Full Text Full Text (PDF) Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                            What's this?

Medicare Advantage: Reforms Needed to Ensure Access to Clinical Trials

Clinical trials are the foundation of progress in the treatment of cancer. Consideration of participation in clinical trial therapy is often the first, best option for a cancer patient. For diseases without effective treatments, a clinical trial may be the only opportunity for treatment. The rigor of clinical trial care serves the patients who participate in them, and the knowledge from trials allows advancement in therapeutic options for future cancer patients.

The 2000 Executive Memorandum that authorized Medicare payment for routine costs of clinical trials provided landmark recognition of the critical role of clinical trials in patient care. However, a . . . [Click for More]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?